Iradimed Corp. (IRMD) Tops Q1 EPS by 3c; Boosts FY16 EPS Outlook

Iradimed Corp. (NASDAQ: IRMD) reported Q1 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $8.96 million versus the consensus estimate of $9.05 million.

GUIDANCE:

Iradimed Corp. sees FY2016 EPS of $0.21-$0.22, versus the consensus of $0.20. Iradimed Corp. sees FY2016 revenue of $9.6-9.7 million, versus the consensus of $9.32 million.

Iradimed Corp. sees FY2016 EPS of $0.88-$0.90, versus prior guidance of $0.83-$0.85 and the consensus of $0.83.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c